Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

AXONICS, INC.

(AXNX)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur AXONICS, INC.
30/11Axonics® CEO Raymond W. Cohen Receives Lifetime Entrepreneurial Achievement Award by th..
17/11Axonics® Ranked the Fastest-Growing Company in North America on the 2021 Deloitte Techn..
08/11Axonics® to Participate in Piper Sandler Virtual Healthcare Conference
05/11Corporate Presentation
04/11AXONICS : Q3 Earnings Snapshot
04/11AXONICS, INC. Management's Discussion and Analysis of Financial Condition and Results ..
04/11Axonics® Reports Third Quarter 2021 Financial Results - Form 8-K
04/11Axonics Q3 Loss Widens, Sales Rise; Cuts Full-Year Revenue Guidance -- Shares Fall Afte..
04/11AXONICS, INC. : Results of Operations and Financial Condition (form 8-K)
04/11Axonics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sept..
04/11Earnings Flash (AXNX) AXONICS Posts Q3 Revenue $46.9M, vs. Street Est of $48.4M
04/11Axonics® Reports Third Quarter 2021 Financial Results
04/11Axonics, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2021
26/10Axonics® Ranked the Fastest Growing Publicly Traded Company in Orange County
07/10AXONICS : reg; to Report Third Quarter 2021 Financial Results on November 4
23/09AXONICS : Confident It Doesn't Infringe Any Medtronic Patent Despite US Patent Office Pane..
23/09MEDTRONIC : Wins US Patent Office's Affirmation On Three Bladder Device Patents
23/09AXONICS : reg; Provides Additional Update on Inter Partes Review Proceedings
23/09Axonics, Inc. Provides Additional Update on Inter Partes Review Proceedings
14/09INSIDER SELL : Axonics
14/09MEDTRONIC : Says US Patent Office Rejects Axonics' Challenge to Bladder Device Patents
13/09AXONICS : reg; Announces Partial Decision on Inter Partes Review Proceedings
27/08AXONICS : reg; to Participate in Upcoming Investor Conferences
05/08AXONICS : Q2 Earnings Snapshot
05/08AXONICS : Management's Discussion and Analysis of Financial Condition and Results of Opera..
05/08AXONICS, INC. : Results of Operations and Financial Condition (form 8-K)
05/08Axonics, Inc. Provides Revenue Guidance for the Fiscal Year 2021
05/08AXONICS : Earnings Flash (AXNX) AXONICS Reports Q2 Revenue $45.9M, vs. Street Est of $39.8..
05/08AXONICS : Earnings Flash (AXNX) AXONICS Posts Q2 Loss $-0.59, vs. Street Est of $-0.49
05/08AXONICS : reg; Reports Second Quarter 2021 Financial Results
05/08Axonics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
19/07AXONICS : reg; Announces Appointment of Dr. Esteban López to its Board of Directors (Form ..
19/07AXONICS, INC. : Change in Directors or Principal Officers, Other Events, Financial Stateme..
15/07AXONICS : reg; Announces Appointment of Dr. Esteban López to its Board of Directors
15/07Axonics, Inc. Names Esteban López to its Board of Directors
14/07AXONICS : BioLife Solutions Announces Changes to Board of Directors
11/07Certain Stock Options of Axonics, Inc. are subject to a Lock-Up Agreement Ending on 11..
11/07Certain Restricted Stock Units of Axonics, Inc. are subject to a Lock-Up Agreement End..
11/07Certain Common Stock of Axonics, Inc. are subject to a Lock-Up Agreement Ending on 11-..
08/07AXONICS : reg; to Report Second Quarter 2021 Financial Results on August 5, 2021
25/06AXONICS, INC. : Submission of Matters to a Vote of Security Holders, Financial Statements ..
25/06AXONICS, INC.(NASDAQGS : AXNX) added to Russell 2000 Defensive Index
25/06AXONICS, INC.(NASDAQGS : AXNX) added to Russell 2000 Growth-Defensive Index
24/06AXONICS : Files Pre-Market Approval Supplement to US FDA for Non-Rechargeable Sacral Neuro..
24/06AXONICS : reg; Files PMA Supplement with the FDA for Non-Rechargeable Implantable Sacral N..
24/06Axonics, Inc. Files PMA Supplement with the FDA for Non-Rechargeable Implantable Sacral..
21/06AXONICS, INC. : Other Events (form 8-K)
20/05AXONICS : Wins FDA Approval for Expanded MRI Labeling
20/05Axonics Receives FDA Approval Further Expanding MRI Labeling
18/05AXONICS : Receives CE Mark Approval for Implantable Sacral Neurostimulator
18/05AXONICS : reg; Announces CE Mark Approval for Implantable Sacral Neurostimulator that Sign..
14/05AXONICS, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statem..
14/05AXONICS : reg; Announces Closing of Public Stock Offering and Full Exercise of Underwriter..
12/05AXONICS : Prices Common Stock Offering at $50 Per Share
12/05AXONICS : reg; Announces Upsize and Pricing of Public Offering of Common Stock
11/05AXONICS : Kicks Off $150 Million Common Stock Offering
11/05AXONICS : reg; Announces Proposed Public Offering of Common Stock
07/05AXONICS : Management's Discussion and Analysis of Financial Condition and Results of Opera..
06/05AXONICS : Q1 Earnings Snapshot
06/05AXONICS : Modulation Tech Widens Q1 Loss
06/05AXONICS, INC. : Results of Operations and Financial Condition (form 8-K)
06/05AXONICS : reg; Reports First Quarter 2021 Financial Results
06/05AXONICS : Earnings Flash (AXNX) AXONICS Posts Q1 Loss $-0.57, vs. Street Est of $-0.41
06/05AXONICS : Earnings Flash (AXNX) AXONICS Reports Q1 Revenue $34.4M, vs. Street Est of $27.9..
06/05Axonics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
06/05Axonics Provides Revenue Guidance for the Year 2021
05/05AXONICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
22/04AXONICS : reg; to Participate in the BofA Securities 2021 Virtual Healthcare Conference
15/04AXONICS : reg; to Report First Quarter 2021 Financial Results on May 6, 2021
01/04AXONICS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial..
31/03Axonics Modulation Technologies, Inc. has Changed its Name to Axonics, Inc
03/03AXONICS MODULATION TECHNOLOGIES, INC : Entry into a Material Definitive Agreement (form 8-..
03/03AXONICS MODULATION TECHNOLOGIES : ® to Participate in the Barclays Global Healthcare Confe..
02/03AXONICS MODULATION TECHNOLOGIES : Endotronix Appoints Industry Veteran Dan Dearen to Board..
02/03AXONICS MODULATION TECHNOLOGIES : ® Announces Strategic Alliance for the Manufacture of Ne..
1  2  3  4  5Suiv.
Prochain événement sur AXONICS, INC.